News & Events

CTI Clinical Trial and Consulting Services Announces Acquisition of Middle East/Northern African based Clinart

September 16, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ September 16, 2020] – CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Clinart, a full-service contract research organization, with nearly 20 years of experience ...

Read More

August New Hires & Promotions

August 31, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Joanna Brown joins as Clinical Research Associate II Carmen Cespedes Cevasco joins as Senior Clinical Research Associate Emily Crawford joins as Senior Clinical Research Associate Barbara McCarty ...

Read More

Consistent Quality Regulation Allows for Multiple COVID-19 Related EUAs

August 31, 2020

As we enter into the ninth month of the COVID-19 pandemic, new SARS-Cov-2 infections continue to occur, both at home in the United States and abroad. World leaders, global health organizations, national and state ...

Read More

CTI and Hepion Pharmaceuticals Announces First NASH Patient Dosed with CRV431 in Phase 2 Clinical Trial

August 13, 2020

FOR IMMEDIATE RELEASE [Covington, KY] August 13, 2020 – CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, and Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focusing on the development of therapeutic drugs for the treatment ...

Read More

CTI and Arcturus Therapeutics Announce Initiation of Dosing of COVID-19 Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 Study

August 11, 2020

Potential for highly differentiated COVID-19 vaccine profile with a single administration, at a low dose Clinical study data expected in Q4 2020 FOR IMMEDIATE RELEASE [San Diego, CA and Covington, KY, August 11, 2020] –Arcturus Therapeutics Holdings Inc. (the “Company”, ...

Read More

Subscribe to our mailing list

* indicates required
What best describes your relationship with CTI?
Areas of Interest (check all that apply)

Please select all the ways you would like to hear from CTI Clinical Trial & Consulting:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

View Privacy Policy